X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

NEW YORK (AP) — A Goldman Sachs analyst on Tuesday issued a “Buy” rating for Walgreen Co., saying that he expects its profit growth to pick up as the drug store operator recaptures lost Express Scripts business and gets a boost from its investment in a Europe-based drugstore chain.

THE BACKGROUND: When a contract between Walgreen and Express Scripts, the nation’s largest pharmacy benefits management company, expired on Dec. 31, Walgreen stopped filling prescriptions for most of Express Scripts’ clients. The companies spent more than a year publicly arguing about the rates Express Scripts pays to drugstores like Walgreen and other issues.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.